BULLETIN V2026-2088
XORTX THERAPEUTICS INC. ("XRTX")
BULLETIN TYPE: Prospectus-Common Share, Pre-Funded Warrant Offering
BULLETIN DATE: June 18, 2026
TSX Venture Tier 2 Company
Financing Type: US Form F-1 Prospectus Offering
Gross Proceeds: US $5,000,000
Offering: 183,577 Listed Shares
2,475,997 Pre-Funded Warrants
Offering Price: US $1.88 per Listed Share
US $1.8799 Pre-Funded Warrant
Warrant Exercise Terms: Each Pre-Funded Warrant is exercisable at $0.0001. The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.
Over-allotment Option: N/A
Commissions in Securities: Shares Warrants
Aggregate # of Brokers: N/A N/A
Broker Warrant Terms: N/A
Disclosure: Refer to the prospectus dated May 13, 2026 and company's news release(s) dated May 14, 2026, May 18, 2026, May 19, 2026.
_______________________________________
|
|
